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Abstract 
 
The prevalence of Cryptosporidium was assessed among 760 children with 
diarrhea in seven districts of the West Bank. Sixty two fecal samples were collected from 
northern, central and southern regions from children without diarrhea as the control 
group. Fecal specimens were concentrated by sedimentation technique and stained by 
modified acid fast staining. Data on each child was obtained and documented. 
Eighty eight (11.6%) of the 760 fecal specimens examined were positive for 
Cryptosporidium. The prevalence rate in females was 12.4% (38/307), and 11.0% 
(50/453) in males. The highest prevalence rate of Cryptosporidium  in Hebron  was 
15.2% (28/184) , followed by Jenin 14.3% (9/63), Nablus 11.1% (7/63), Qalqilya 10.8% 
(16/148), Toulkarm 10.7% (6/56), Ramallah 9.3% (12/129), and Bethlehem 8.5% 
(10/117). The prevalence rate was found to be slightly higher in camps (12.9%) than 
villages (12.2%) and cities (9.8%). This can be due to the poor hygienic and sanitary 
conditions. The prevalence rate of Cryptosporidium in the control group was 3.2% (2/62) 
which is consistent with other previous studies. 
Significant difference in the prevalence rate of Cryptosporidium was clearly 
detected among different age groups. The age group (<5 years) is extremely higher 
(14.4%) than other groups; (5-10 years) age group (7.7%) and (10-15 years) age group 
(5.9%).. This may be due to lack of sanitary practice, self awareness and personal 
cleanliness in (0-5 years) group of children because they tend to put every thing in their 
mouths without awareness. 
viii 
The data suggest that there is a need to implement routine testing for Cryptosporidium on 
all diarrheal stool specimens obtained from children. This study necessitates the re-
evaluation of the current standards for safe drinking water. The Ministry of Health should 
develop new strategies to prevent the transmission of cryptosporidiosis.  
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CHAPTER ONE 
 
 
                                                                                                                                                       
1.1 Introduction 
 
 Diarrheal diseases are extremely common in developing and developed countries.  
They are responsible for morbidity and mortality of millions of individuals each year 
(Verweij, et al., 2004). The intracellular parasite, Cryptosporidium is considered to be 
one of the most important enteric pathogens with world-wide distribution (Current, 1994; 
Mclauchlin, et al., 2000). 
Many studies indicate that Cryptosporidium oocysts  are  present in 65-97% of  
surface water  in  the U.S.A and oocysts  are found  in relatively smaller numbers in the 
range of 27%-54%  in fully treated (disinfected and filtered) municipal water (Juranek, 
1995) .   
Accurate data are not yet available on the extent of Cryptosporidium world 
distribution; however estimates indicate that 5-10% of reported diarrheal disease in 
developing countries compared to 1-3% in the developed countries is caused by 
Cryptosporidium species (Kehl, et al., 1995). 
In children with diarrhea, Cryptosporidium is one of the most common enteric 
pathogens recovered (Current, 1994). The rate of infection is predicted to be higher in 
malnourished children (Sallon, et al., 1988; Current, 1994; Hunter and Nichols, 2002). A 
study was carried out among 240 Iraqi children (under five years of age) presenting with 
a primary diagnosis of diarrhea. They found that Cryptosporidium oocysts were excreted 
by 8.8 % (21/240) of children (Mahdi, et al., 1996). 
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A study has been conducted on 265 children under five  years of age in Irbid-
Jordan (Youssef, et al., 2002). They found that the prevalence of Cryptosporidium is 
1.5% compared to 32.5% rotavirus and 12.8% enteropathogenic Escherichia coli 
(Youssef, et al., 2002).The prevalence of Cryptosporidium in Egypt, in children with 
diarrhea was reported to be 16.6% in 1986, 11.6% in 1987 and 27.9% in 1995 (Michel, et 
al., 2000). 
 
A study has been conducted in Rawalpindi, Pakistan, to investigate the prevalence 
of Cryptosporidium among 475 young children with acute diarrhea and 150 children as 
control group. They found that the prevalence of the parasite in children with acute 
diarrhea is 10.3% compared to 3.3% in the control group (Iqbal, et al., 1999). A hospital 
based study was carried out on 2095 patients of all ages in north eastern India. The 
prevalence of Cryptosporidium was found to be 7.2% (Nath, et al., 1999). 
 
 A three-year survey has been conducted in Taiwan to examine water samples and 
fecal specimens for Cryptosporidium and Giardia. They found that the percentage of 
these two parasites in 10 large water plants are 70% and 75% respectively. Fecal 
specimens from 9 species of animals indicate a prevalence of 20% (22/110) for 
Cryptosporidium and 10% (11/110) for Giardia (Hsu, et al., 2002).       
                         
Additional reports have further documented the ability of Cryptosporidium to 
cause infection even when ingested in relatively small amounts of fully chlorinated water 
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that follows the standard methods for safe water drinking (DuPont, et al., 1995; 
Carpenter, et al., 1999).       
1.2 Significance of the Study 
 
This study can be considered as a comprehensive study on the prevalence of 
Cryptosporidium in the West Bank, Palestine. No records were detected on the 
prevalence of the parasite in this part of Palestine except for the work by (Sallon, et al, 
1988).  
The study would help in the following points:  
• Data obtained from this study can serve as a starting point for future studies. 
• Development of new strategies by the Ministry of Health to control the transmission of 
Cryptosporidium by evaluating the current standards for safe drinking water. 
1.3 Objectives 
The main objective of this study is to increase the awareness among health care givers 
about Cryptosporidium. It also signifies the need for the routine examination of all 
diarrheal fecal specimens for the presence of oocysts of this parasite 
Specifically: 
• To screen for Cryptosporidium in fecal samples of children with diarrhea in the West 
Bank. 
• To investigate the prevalence of Cryptosporidium by district geographical locations in 
the West Bank. 
• To investigate the prevalence of Cryptosporidium by gender. 
• To determine if the prevalence of Cryptosporidium is age related. 
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• To determine the prevalence of Cryptosporidium in the control group (children without 
diarrhea) 
 
 1.4 Characteristics of Cryptosporidium 
 
Cryptosporidium is an intracellular protozoan parasite that has emerged as an 
important cause of diarrhea in humans and animals (Dalle et al., 2003). It belongs to the 
Phylum, Apicomplexa  and Coccidia subclass (Liu, et al., 1999).  
 
Since 1982,  Cryptosporidium  has  been increasingly recognized  as a  cause  of 
severe  and  life-threatening  diarrhea in patients with  AIDS (Juranek, 1995; Hellard, et 
al., 2003). The disease is severe, prolonged and chronic in immunocompromised patients 
and malnourished children but is a self -limiting disease in immunocompetent individuals 
(Current, et al., 1983; Newman, et al., 1994; Clark, 1999; Fayer et al., 2000).  
 
Cryptosporidium establishes a compartment within the host cell, which is 
morphologically different from the setting used by the related parasites. So this unique 
parasitophorous vacuole may shelter the parasite from antimicrobial drugs (Clark, 1999). 
Cryptosporidium oocysts are the infective stages for the transmission and survival 
of the organism in the environment. The oocyst is not a static structure, but it is able to 
incorporate antigens by a mechanism involving vesicle fusion with the intestinal wall and 
the incorporation of the antigen to the outer oocyst wall (Entrala, et al., 2001). 
 
Cryptosporidium oocysts are remarkably resistant to many common disinfectants, 
including chlorine-based compounds. Oocysts are heat sensitive; a temperature of 65 C 
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inactivates oocysts in 5-10 minutes. Desiccation over a period of 2 hours or more is lethal 
to oocysts. Oocysts can remain viable for about 18 months in a cool, damp or wet 
environment (Robertson, et al., 1992). They are quite common in rivers and lakes, 
especially where there has been sewage or animal contamination. They are generally 
susceptible to freezing, although this varies by onset of freezing; snap freezing destroys 
oocysts reliably, but with slow freezing, such as that found in natural environment, 
oocysts have been reported to survive  temperatures as low as -22 C (Juranek, 1995). 
 
Transmission of the parasite occurs by the fecal-oral route through the ingestion 
of oocysts present in water or food that shed in feces of infected hosts (Dalle, et al., 
2003). The small size of the Cryptosporidium oocyst and its resistance to many chemical 
disinfectants, pose a challenge for standard filtration and disinfection procedures. 
Moreover, the low dose for infection and the prolonged excretion of high numbers of 
oocysts make Cryptosporidium ideal for waterborn transmission (Carpenter, et al., 1999). 
 
1.5 Cryptosporidium Taxonomy: 
        Members of the genus Cryptosporidium are placed taxonomically in the phylum 
Apicomplexa, class Conoidasida, subclass Coccidiasina, order Eucoccidiorida, suborder 
Eimeriorina, and family Cryptosporidiidae (Bulter and Mayfield, 1996). Thirteen 
Cryptosporidium species are currently identified on the basis of oocyst morphology, 
natural host specificity, and genetic characterizations (Xiao, et al., 2004); (Table 1.1). 
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Table 1.1 Currently identified species of Cryptosporidium 
 
 
Cryptosporidium species 
 
Origin of isolate 
C. parvum  Cattle, Human and other 
mammals 
C. hominis  Humans 
C. andersoni  Cattle 
C. wrairi  Guinea pigs 
C. muris  Rodents 
C. felis  Cats 
C. canis  Dogs 
C. meleagridis Birds 
C. galli Birds 
C. baileyi Birds 
C.molnari Fish 
C. saurophilum  Snakes and Lizards 
C. serpentis  Snakes and Lizards 
 
          (Xiao, et al., 2004) 
      
      At least five different species of Cryptosporidium have been recognized to infect 
human, although each Cryptosporidium species or genotype has specific host specificity. 
These types are: human genotype C. parvum, bovine genotype C. parvum, C. 
meleagridis, C. felis, and C. canis, respectively in the order of their prevelance in human 
(Limor, et al., 2002).      
     There are two distinct genotypes of Cryptosporidium parvum, Genotype I which was 
recognized in human isolates and Genotype II in calves isolates or humans isolates who 
were exposed to calf feces (Fleming, et al. 1999). 
     Anthroponotic and zoonotic life cycles could occur in human infections with 
Cryptosporidium (CDC, 2003; Alves, et al., 2003), because human cryptosporidiosis is 
mainly caused by C.parvum and C. hominis (C. parvum human genotype). C. parvum is 
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found in human, wild animals, and domestic livestock, whereas C. hominis is found 
almost exclusively in human (Alves, et al., 2003). 
 
1.6 Life Cycle 
 
The life cycle of Cryptosporidium is completed within one host. The resistant 
stage found in the environment is the thick-walled oocyst, containing four sporozoites 
(Bulter and Mayfield, 1996). The mature and sporulated oocysts (5 µm) are shed in the 
feces of infected humans or animals, each containing 4 sporozoites (Clark, 1999). The 
oocysts are ingested by other suitable hosts through contamination of environment, water 
or food (CDC, 2003). 
 Sporozoites excyst from the oocyst (excystation process) and parasitize epithelial 
cells of the gastrointestinal tract, then the sporozoites differentiate into a spherical 
trophozoite (Bulter and Mayfield, 1996), and asexual multiplication occurs, forming two 
types of meronts (schizonts), type I meronts contain 6-8 nuclei, which become 
incorporated into 6 to 8 merozoites (CDC, 2003). 
 
When the meront is mature, each merozoite is able to infect a new host cell and 
then develops either into type I meront or type II meront, which contains 4 merozoites 
when mature (Clark, 1999). 
 
 The merozoites from type II meronts also invade new host cells but they initiate 
sexual multiplication by differentiating into either microgamont (male) or macrogamont 
(female) stages (CDC, 2003). Upon fertilization of the macrogamonts by microgamonts, 
the fertilized macrogamon (zygote) then develops into an oocyst that sporulates within 
the infected host by undergoing mitosis (Chen, et al., 2002; CDC, 2003). 
  8 
 
When meiotic sporozoite formation (sporogony) is completed, each oocyst 
becomes containing 4 potentially infective sporozoites (Chen, et al., 2002). There are two 
types of oocysts produced during the cycle , the thick-walled oocysts (80%) which are 
commonly excreted from the body in the feces, and the thin-walled (20%) which are 
involved in autoinfection because they excyst within the gut, they release merozoites and 
infect new host cells (Bulter and Mayfield, 1996; CDC, 2003). 
 
 Each generation of the parasite can develop and mature within 12-14 hours, so the 
rapid life cycle and the autoinfection cycles together may lead to the production of huge 
numbers of parasitic cells in the gut and to secondary infection sites in the duodenum and 
large intestine (Bulter and Mayfield, 1996; Figure 1.1). 
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Figure 1.1 Life cycle of Cryptosporidium parvum and C. hominis (CDC, 2003). 
 
1.7 Mode of transmission:  
 The infective stage is the sporulated oocyst that is shed in feces of infected 
people. The infection may be acquired in a number of ways such as contaminated water, 
animal-contact, person to person contact especially in children day care centers, and 
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contaminated food such as vegetables, fruits, raw meat and unpasteurized milk (Juranek, 
1995). 
 In a study that has been conducted to demonstrate the infectivity of 
Cryotosporidium on 29 health volunteers, they found that 20% (6/29) became infected 
after receiving a dose of 30 oocysts. The infectivity became 88% (14/16) when 16 
healthy volunteers had received 300 oocysts and 100% of the healthy volunteers became 
infected after receiving a dose of 1000 oocysts (DuPont, et al., 1995). 
1.8 Diagnosis 
Cryptosporidial oocysts can be examined by wet mount preparation stained with 
iodine, especially specimens containing moderate to high numbers of oocysts (CDC, 
2003). The modified acid-fast stain is usually used to detect the presence of 
cryptosporidial oocysts in fecal samples (Alles, et al., 1995; Verweij, et al., 2004). 
Diagnosis of Cryptosporidium can be done also using immunofluorescent 
antibody (IFA) and enzyme immuno assay (EIA) (Guerrant, 1997; Fleming, et al., 1999). 
However, the microscopic identification of Cryptosporidium requires well-trained and 
experienced microscopists (Kehl, et al., 1995;  Alles, et al., 1995; Morgan  et al., 1998 ; 
Johnston, 2003). Immunodetection of antigens on the surface of the organism in fecal 
specimens using monoclonal antibodies is the gold standard for the diagnosis of 
Cryptosporidium (CDC, 2003; Johnston, 2003).  
Using direct immunofluorescent antibody (DFA) resulted in a significantly 
increased detection rate of Cryptosporidium by 69.6% (39 positive samples, p=0.005) 
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compared with conventional staining methods (23 positive samples)  from a total number 
of 2696 fresh stool specimens examined in the routine practice of parasitology section in 
Massachusetts general hospital, Boston (Alles et al., 1995).  
Another study has been performed on 511 fecal specimens to compare between 
conventional methods (modified acid fast stain) and a recently developed polymerase 
chain reaction technique (PCR), they found that 36 positive cases of Cryptosporidium 
were identified using PCR, while 29 positive cases were identified using routine 
microscopy, therefore conventional methods exhibited 98.9% specificity and 83.7% 
sensitivity compared to 100% specificity and sensitivity to PCR method (Morgan, et al., 
1998). 
 Many genotyping methods have been developed to improve the understanding of 
the route of transmission of Cryptosporidium isolates, such as PCR-restriction fragment 
length polymorphism (RFLP) and light cycler PCR for the real-time detection and 
differentiation of Cryptosporidium (Limor, et al., 2002). 
  An optimized method to maximize the DNA extraction of Cryptosporidium 
parvum from small numbers of purified and partially purified oocysts present in mineral 
water sources by 15 cycles of freezing with liquid nitrogen and thawing at 65 C in a lysis 
buffer containing sodium dodecyl sulfate (Nichols and Smith , 2004). 
  The initial amplification of Cryptosporidium DNA using a conventional 
thermocycler followed by real-time PCR using a lightCycler with SYBR Green I is a 
novel approach for the identification of Cryptosporidium species, especially C. parvum 
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and C. hominis, in environmental samples with heterogeneous mixtures of 
Cryptosporidium species (Amar, et al.,  (2004). 
1.9 Clinical Features 
 
Infection with Cryptosporidium species results in a wide range of clinical 
manifestations, from asymptomatic infections to severe and life-threatening illness (CDC, 
2003). In immunocompetent individuals, cryptosporidiosis is accompanied by watery 
diarrhea, dehydration, weight loss, abdominal pain, nausea, vomiting, and fever. 
symptoms are usually resolved within 1-2 weeks (Juranek, 1995); but the symptoms can 
be chronic and more severe in immunocompromised patients (Clark, 1999). 
Symptomatic Cryptosporidium infection have also been recognized in other 
organs including other digestive tract organs, lungs, but the small intestine is the site most 
commonly affected with the parasite (CDC, 2003). Cryptospopridiosis is widely 
prevalent in malnourished children, patients following solid-organ transplantation, 
malignant diseases, primary immunodeficiency diseases and to a lesser extent in diabetic 
patients (Hunter and Nichols, 2002). 
 
1.10 Epidemiological Aspects of Cryptosporidium:  
 
 The parasite was first recognized in 1907 by Clarke and Tyzzer (Hunter and 
Nichols, 2002). During the 1970s, this organism became well known to Veterinary 
workers, and was reported as the causative agent of human cryptosporidiosis at the Johns 
Hopkins School of medicine in 1976 (Guerrant, 1997).  
Seven cases of cryptosporidiosis were reported in humans in the period between 
1976 until 1982, five of them were in immunsuppressed patients (Guerrant, 1997). Since 
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1982, as the prevalence figures began to rise, Cryptosporidium has been increasingly 
implicated as a cause of severe and life-threatening diarrhea in AIDS patients (Current, 
1983). By 1984, 58 cases of cryptosporidiosis were reported, 40 cases were found in 
immunocompromised patients and 33 cases were detected in patients with AIDS (83%). 
Among the immunocompramised patients, 55% of the 40 patients died (Guerrant, 1997). 
   By the early 1990s, Cryptosporidium was identified as a major cause of 
community gastroenteritis causing outbreaks associated with drinking water, swimming 
pools, and exposure to animals (Hellard, et al., 2003). 
 Seroepidemiologic studies showed a prevalence of IgG antibodies to 
Cryptosporidium parvum. In Brazil, 90% of children had serologic evidence of 
Cryptosporidium infection in their first year of life. 17%-32% by adulthood in the U.S.A 
had serologic evidence of Cryptosporidium infection by adulthood. More than 50% of 
children in China had serologic evidence by 5 years of age (Guerrant, 1997). 
 The seropositivity of Cryptosporidium-specific antibodies (IgM and IgG) was 
94.6% in a study conducted on 223 members of 31 housholds with children younger than 
3 years of age in an urban slum in Fortaleza, Brazil; and who were diagnosed as positive 
for Cryptosporidium oocysts in stool examination (Newman, et al., 1994). 
A review  of 100 reports of more than 133,175 patients with diarrhea showed  
infection of Cryptosporidium in  the range of  0.26% -22% of  immunocompetent persons  
in  developed countries and 1.4% - 40.9% in developing countries (Guerrant, 1997; Chen, 
et al., 2002). The rate of Cryptosporidium infection among HIV infected persons ranges 
from 6%-70% in developed countries and 8.7-48% in developing countries (Guerrant, 
1997); Table1.2) 
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Table 1.2 Rates of Cryptosporidium infection among immunocompetent and HIV-
positive patients in developing and developed countries (Guerrant, 1997). 
 
_____________________________________________________________________ 
  Countries                 Patients with diarrhea         Controls without diarrhea 
_____________________________________________________________________ 
 
1-HIV-Positive: 
 
a. Developed countries        14 %( 6%-70%)                         0 %( 0%-0%)                       
                                               [n=148/1074]                             [n=0/35] 
 
b. Developing countries     24 %( 8.7%-48%]                       5 %( 4.9%-5.3%) 
                                                [n=120/503]                              [n=5/101] 
 
2- Immunocompetent: 
 
a. Developed countries      2.2 %( 0.26%-22%)                     0.2 %( 0%-2.4%) 
                                               [n=2232/107329]                       [n=3/1941] 
 
b.Developing countries     6.1 %( 1.4%-40.9%)                     1.5 %( 0%-7.5%) 
                                               [n=1486/24269]                             [n=61/4146]  
______________________________________________________________________ 
 
 
 
1.11 Cryptosporidium outbreaks 
 
Numerous well-documented outbreaks of cryptosporidiosis have occurred. Most 
of these were waterborne outbreaks. They resulted from problems in the filtration and 
flocculation processes associated with water treatment plants. Numerous waterborne 
Cryptosporidium outbreaks have been described, mainly in the United States of America, 
European countries, Japan, and Canada (Dalle,  et al., 2003).   
 The most serious outbreak was recognized in April, 1993 in Milwaukee, 
Wisconsin, U.S.A. An estimated 403,000 persons were infected by drinking water 
contaminated with Cryptosporidium (Chen, et al., 2002). The suspected cause was due to 
errors in treatment, possibly contamination of filtered water with raw, unfiltered water. 
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Other operation-related problems were also suspected such as inadequate monitoring of 
water turbidity and inoperable equipment (Mackenzie, et al., 1994).  
 
This outbreak is the largest waterborne outbreak in the United States history. The 
incidence rate was 52% among those served by the South Milwaukee Water Works Plant. 
Consequently, many immunocompromised patients died and many healthy persons 
become ill. The mean duration of illness was 12 days with a range of 1 to 55 days, and 
the average maximum number of watery diarrheal stools was 19 per day at the peak of 
the illness.  Watery diarrhea was the predominant symptom among 93% of confirmed 
cases (Mackenzie et al., 1994).  
 
Chlorinated recreational water facilities have been implicated in many outbreaks 
of cryptosporidiosis during the last decade. Standards for water purity in the United 
States have been strengthened in response to cryptosporidiosis outbreaks; however small 
numbers of oocysts can still breach water filtration in a 25-50% the communities with 
strengthened standards (Carpenter, et al., 1999).  
 
Additional outbreaks in public swimming pools and wade pools have further 
documented the ability of Cryptosporidium to cause infection even when ingested in 
relatively small amounts of fully chlorinated water that follows the standard methods for 
safe drinking water (Guerrant, 1997).  
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1.12 Pathogenesis and Immunologic Features 
Subsequent to oocyst excystation, the released sporozoites usually adhere to the 
surface of intestinal mucosa via a sporozoite specific-lectin adherence factor (Bulter and 
Mayfield, 1996). The watery nature of the diarrhea associated with Cryptosporidium 
infections has suggested the presence of an enterotoxin; however, no enterotoxin has 
been purified from fecal extracts (Guerrant, 1997). 
Experimental evidence suggests that glucose-coupled Na+ absorption is decreased 
and Cl- secretion is increased, therefore, the diarrhea associated with Cryptosporidium 
appears to be primarily osmotic in nature (Clark, 1999). Epithelial mucosal cells release 
cytokines that activate phagocytic cells.  These activated cells start releasing large 
amounts of soluble factors (histamine, serotonin, adenosine, prostaglandins, leukotriens 
and platelet activating factor) that increase intestinal secretion of water and chlorine and 
also inhibit intestinal absorption (Chen, et al., 2002). 
The soluble factors act on different substrates including enteric nerves leading to 
epithelial cell damage through T cell mediated inflammation and producing villus 
atrophy and crypt hyperplasia which are accompanied by mixed inflammatory cell filtrate 
within the lamina propria, consequently, intestinal absorption is impaired and secretion is 
enhanced (Bulter and Mayfield, 1996; Figure 1.2) 
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     Figure 1.2 Pathogenesis of Cryptosporidial Enteropathy and Cholangiopathy:  
The organism activates a second-signal pathways, such as the nuclear factor-B (NF-B) 
and c-src systems. Activation of NF-B induces the production of cytokines and 
chemokines, such as interleukin-8, which triggers an inflammatory reaction and 
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stimulates anti-apoptotic survival signals in directly infected cells. C. parvum induces 
secretion of 5-hydroxytryptamine (5-HT) and prostaglandin E2 (PGE2) into the lumen of 
the small intestine (Chen, et al., 2002). 
 Macrophages produce tumor necrosis factor (TNF) in the lamina propria, but TNF 
doesn’t directly affect epithelial transport. Adding a fibroblast monolayer, an 
indomethacin-inhibtable secretory effect with TNF was noted.  Researchers suggested a 
prostaglandin-dependent secretory effect through a bumetanide –inhibitable chlorine 
secretory pathway (Guerrant, 1997; Figure 1.3). 
 
Figure 1.3 Schematic representation of Cryptosporidium pathogenesis: 
An increased intercellular permeability and inflammation in the submucosal layer has 
been associated with Cryptosporidium infection.  Macrophages secreting tumor necrosis 
factor-alpha (TNF-) or other cytokines may stimulate fibroblasts and other cells in the 
  19 
lamina propria to secrete prostoglandins (PGE). So, this promotes secretion and impair 
absorption (Clark and Sears, 1996).  
 Cryptosporidium parvum activates a nuclear factor B (NF-B) system which 
infects biliary epithelial cells. So the release of NF-B associated cytokines and 
chemokines has a critical role in the pathogenesis of inflammation associated 
cryptosporidiosis. C. parvum induces epithelial cell apoptosis in biliary infection and this 
was appeared to be associated with the Fas receptor-Fas ligand death pathway, but this 
mechanism of cell death has not been confirmed in vivo (Farthing, 2000) . 
1.13 Cryptosporidiosis in Palestine 
 
Epidemiological data on the prevalence of Cryptosporidium infections seem to be 
very sparse in most of the developing countries including Palestine. Caritas Baby 
Hospital-Bethlehem, Palestine; is the only hospital that routinely tests for the presence of 
Cryptosporidium in children’s fecal samples. Oocysts are detected microscobically both 
in wet mounts and stained fecal preparations. 
There is a high probability for mis-diagnosed cases with   Cryptosporidium. This 
may be due to lack of experience of the technicians to detect the small size 
Cryptosporidium’s oocysts.  
 A study has been conducted at Caritas Baby Hospital on 221 children with 
gastroenteritis, showed that the prevalence of Cryptosporidium to be 13.5% compared to 
7.2% Entamoeba histolytica, 3.6% Giardia, 11.3% Salmonella, and 0.9% Shigella 
(Sallon,  et al.,1988). 
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A one year perspective study was carried out in Gaza on 1225 children with 
diarrhea; the major pathogens were 18.5% Salmonella, 14.6% Cryptosporidium, 6.8% 
rotavirus, and 8.3% Campylobacter species (Sallon, et al., 1994). So this percent of 
Cryptosporidium in stool samples indicates a very high prevalence rate, but it needs to be 
examined further in all over Palestine.    
 
1.14 Prevention 
 
The effective control measures should be aimed toward preventing the 
transmission of the oocysts. While keeping in mind the resistant nature of oocysts to 
many chemical disinfectants and antiseptics (Chen et al, 2002;  Carpenter, et al. 1999). 
However Ozone is probably the most effective chemical agent in inactivating 
Cryptosporidium oocysts (Guerrant, 1997). The maintenance of immune system 
functions by the use of HAART is the best way to prevent cryptosporidiosis in AIDS  
patients (Clark, 1999).  
1.15 Treatment 
 
Although there is no reliable therapy for cryptosporidiosis. There are many agents 
used to reduce the infection (Chen, et al., 2002).  The treatment options depend mainly on 
the immunologic conditions of the patient (Guerrant, 1997). In immunocompetent 
individuals, no specific therapy is indicated because the disease is self-limiting. Oral or 
intravenous fluids and electrolytes replacement may correct the dehydration and acute 
diarrhea (Chen et al., 2002; Clark, 1999). Nitazoxanide has provided some encouraging 
results in the management of diarrhea in immunocompetent patients (CDC, 2003), but the 
most widely used one is paromomycin (Clark, 1999; Guerrant, 1997), however it doesn’t 
eradicate the parasite but it reduces oocysts number and decreases the frequency of the 
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diarrhea (Guerrant, 1997). 
In AIDS patients, the ideal treatment is strengthening the immune function of the 
body by administering Highly Active Antiretroviral Therapy (HAART), to help in 
resolving the infection (Chen et al 2002; Clark, 1999). If HAART therapy is not 
effective, several antibiotics can be used (paromomycin, nitazoxanide, and azithromycin).  
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CHAPTER TWO 
 
Material and Methods 
2.1 Study design 
This study comprises 760 fecal specimens of human origin associated with 
diarrhea, in addition to 62 samples as control group in children without diarrhea. These 
samples were collected in the period between Septemper 2003 and November 2004 from 
hospitals, in Ramallah (n=129)-Ramallah Governmental Hospital, Bethlehem (n= 117) - 
Caritas Baby Hospital, Hebron (n= 184) -Alia Hospital, Jenin (n= 63) - Governmental 
Hospital, Nablus (n= 63) - AL-Watani Hospital, Qalqylia (n= 148) - Qalqylia Hospital, 
and Tulkarm (n= 56) - Governmental Hospital. 
 
 The fecal samples of the control group were collected from southern, central and 
northern regions of the West Bank. Twenty one samples were collected from Alia 
Hospital-Hebron (southern region). Twenty one samples were collected from Ramallah 
Governmental Hospital-Ramallah (central region) and twenty samples were collected 
from the Governmental Hospital-Jenin (northern region). 
 
2.2 Study population 
 The target group for this study was children between ages of less than one year to 
15 years of age. The samples collected were representative of the population in terms of 
gender, region and age as described in the following table. 
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Table 2.1 Distribution of samples by district. 
Region District 
city village Camp Total 
Bethlehem 25 73 19 117 
Hebron 45 116 23 184 
Jenin 23 21 19 63 
Nablus 24 23 16 63 
Qalqilya 60 88 - 148 
Ramallah 42 53 34 129 
Tulkarm 15 20 21 56 
Total 234 394 132 760 
 
 
Table 2.2 Distribution of samples by gender.  
 
 
Gender  
District Female Male 
Total 
 
Bethlehem 54 63 117 
Hebron 61 123 184 
Jenin 29 34 63 
Nablus 27 36 63 
Qalqilya 56 92 148 
Ramallah 55 74 129 
Tulkarm 25 31 56 
Total 307 453 760 
 
 
Table 2.3 Distribution of samples by age categories.  
 
 
Age Categories Total District 
>0-5 >5-10 >10-15  
Bethlehem 117 -- -- 117 
Hebron 104 47 33 184 
Jenin 28 24 11 63 
Nablus 35 22 6 63 
Qalqilya 73 49 26 148 
Ramallah 69 41 19 129 
Tulkarm 38 12 6 56 
Total 464 195 101 760 
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2.3 Sample Collection and Processing 
 Fecal samples were collected in a dry, clean, leakproof plastic container. Each 
sample was labeled with the child’s name, gender and age. Additional information about 
each sample was obtained from the hospital (place of residency and patient’s hospital 
number).  
2.3.1 Formalin fixation 
One volume of the fecal sample was mixed thoroughly using wooden applicator 
stick, with 3 volumes of 10% formalin. The sample was mixed again, and the specimen 
containers were sealed well. All samples were reinforced with parafilm, the container was 
inserted in a plastic bag, and samples were stored at 4 C (CDC, 2003; Johnson, et al., 
2003).  
 2.3.2 Formalin-ethyl acetate sedimentation technique: 
To maximize the recovery of oocysts, fixed-fresh stool samples were concentrated 
prior to microscopic examination using ethyl acetate sedimentation method as 
recommended by the Center of Disease Control and Prevention (CDC, 2003). 
Concentration procedures separate parasites from fecal debris and increase the chances of 
detecting oocysts (Garcia, 1999). 
Procedure: 
- The specimen was mixed well. 
 - 5ml of the fecal suspension were strained through wetted cheesecloth-type gauze 
placed over a disposable paper funnel into a 15 ml centrifuge tube. 
- 0.85% saline was added through the debris on the gauze to bring the volume in the 
centrifuge tube to 15ml.  
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-  Sample was centrifuged at 500 x g for 10 minutes. 
- Supernatant was decanted. Then 10 ml of 10% formalin were added to the sediment and 
mixed thoroughly with wooden applicator stick. 
- 4 ml of ethyl acetate were added, the tube was stoppered, and shook vigorously in an 
inverted position for 30 seconds.  
- Each sample was centrifuged again at 500 x g for 10 minutes. 
- The plug of floating debris was removed from the top of the tube by ringing the sides 
with an applicator stick. The top part of supernatant was decanted. 
- A cotton-tipped applicator was used to remove debris from the sides of the centrifuge 
tube. 
- Five drops of 10% formalin were added to resuspend the concentrated specimen.  
2.3.3 Modified acid fast staining:  
I- 50% Ethanol: 
 50 ml of absolute ethanol were added to 50 ml of distilled water and the solution was 
stored at room temperature; the solution is stable for 1 year (Garcia, 1999).  
II- Kinyoun’s Carbol Fuchsin: 
 4 g of basic fuchsin were dissolved in 20 ml of 95% ethanol (Solution A) and 8 gram of 
phenol crystals were dissolved in 100 ml of distilled water (Solution B), the two solutions 
A and B were mixed, and the solution was stored at room temperature; the solution is 
stable for 1 year (Garcia, 1999). 
III- 1% Sulfuric Acid: 
One ml of concentrated sulfuric acid (98%) was added to 99 ml of distilled water and the 
solution was stored at room temperature; the solution is stable for 1 year (Garcia, 1999).  
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IV- Loeffler Alkaline Methylene Blue: 
 0.3 g of methylene blue was dissolved in 30 ml of 95% ethanol and the solution was 
stored at room temperature; the solution is stable for 1 year.  
 Procedure: 
The procedure by (Garcia, 1999) was followed in staining fecal specimens: 
- A thin smear of 1 to 2 drops of specimen prepared on a slide and allowed to air dry.  
- Specimens were fixed with absolute methanol for 1 minute. 
- Specimens were stained with Kinyoun’s carbol fuchsin for 5 minutes, then rinsed 
briefly with distilled water and drained. 
-The slide was rinsed briefly (3 to 5 seconds) with 50% ethanol. 
-The slide was rinsed thoroughly with distilled water and drained. 
- Decolorization by using 1% aqueous solution of sulfuric acid for 2 minutes or until 
color stopped running off the slide. 
- The slide was rinsed with distilled water and drained. 
- The slide was counterstained with methylene blue for 1 minute. 
- The slide was rinsed with distilled water, drained, and air dried. 
- Specimens were examined microscopically using the 100x oil immersion objective lens.  
- The slide was considered positive if red oocysts are seen  and negative if red colored 
oocysts are not seen. 
2.4 Statistical analysis: 
Chi square (2) test was used to establish the p value using SPSS program.   
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CHAPTER THREE 
Results 
A total of 760 children with diarrhea, 307 females and 453 males aged (> 0-15) 
years old were surveyed for Cryptosporidium infection in seven districts (Bethlehem, 
Hebron, Jenin, Nablus, Qalqilia, Ramallah and Toulkarm)  in the period between 
September 2003 and November 2004. Out of 760 fecal samples, 88 samples were 
positive, being infected with Cryptosporidium spp. a prevalence rate (11.6%, 88/760); 
Table 3.1). 
Cryptosporidial oocysts stained red with visible sporozoites with light blue 
background under light microscope; Figure 3.1 and 3.2. 
 
Figure 3.1 Cryptosporidial oocysts under light microscope (100X) stained by modified 
acid fast stain. 
 
Figure 3.2 Cryptosporidial oocysts with visible sporozoites under light microscope 
(100X), stained by modified acid fast stain. 
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3.1 Prevalence of Cryptosporidium in the seven assayed districts 
 The Prevalence rate was found to be comparable among the seven districts and 
there is no significant difference in the prevalence rate of Cryptosporidium (P>0.05) but 
it was slightly higher in Hebron and Jenin districts than other districts. The prevalence 
rate was as follows; Hebron district (15.2%, 28/184), Jenin district (14.3%, 9/63), Nablus 
(11.1%, 7/63), Qalqilia district (10.8%, 16/148), Toulkarm (10.7%, 6/56), Ramallah 
(9.3%, 12/129) and Bethlehem district (8.5%, 10/117; Figure 3.3). 
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Figure 3.3 Prevalence of Cryptosporidium in the seven assayed districts. 
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3.2 Prevalence of Cryptosporidium in the seven districts by region (city, village 
and camp) 
 
 The prevalence rate was not found to be significantly different between the three 
regions ((P>0.05) in all districts, but the prevalence of the parasite was found to be higher 
in camps than villages and cities. The prevalence rate of Cryptosporidium in the different 
regions was as follows; camps (12.9%, 17/132), villages (12.2%, 48/394) and cities 
(9.8%, 23/234; Figure 3.4). 
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Figure 3.4 Prevalence of Cryptosporidium in the seven districts by region (city, 
village and camp). 
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3.3 Prevalence of Cryptosporidium in the seven districts by gender  
 The prevalence rate of Cryptosporidium infection was slightly higher in females 
(12.4%, 38/307) than in males (11.0%, 50/453), but there was no significant statistical 
difference between males and females on the prevalence rate of the parasite (p>0.05); 
Figure 3.5). 
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Figure 3.5 Prevalence of Cryptosporidium in the seven districts by gender. 
 
3.4 Prevalence of Cryptosporidium in the seven districts by age categories 
 The prevalence rate of Cryptosporidium infection was found to be significantly 
different between age categories, and the prevalence rate was extremely higher in the age 
category (>0-5) than other categories (P<0.05); the prevalence rate of the parasite in the 
different age categories was as follows; 0-5 age category (14.4%, 67/464), >5-10 age 
category (7.7%, 15/195) and >10-15 age category (5.9%, 6/101; Figure 3.6). 
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Figure 3.6  Prevalence of Cryptosporidium in the seven districts by age categories. 
 
3.5 The prevalence rate of Cryptosporidium in each district by city 
The prevalence rate of Cryptosporidium infection was moderately higher in 
Hebron and Jenin in comparison with other cities, but there was no significant difference 
between cities of different districts on the prevalence rate (P>0.05). The prevalence rate 
was as follows;  Hebron city (15.6%, 7/45), Jenin city (13.0%, 3/23), Qalqilya city 
(10.0%, 6/60), Nablus city (8.3%, 2/24), Bethlehem city (8.0%, 2/25), Tulkarm city 
(6.7%, 1/15) and Ramallah city (4.8%, 2/42)( Figure 3.7). 
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Figure 3.7  The prevalence of Cryptosporidium in each district by city.  
3.6 The prevalence rate of Cryptosporidium in each district by camps 
The prevalence rate was found to be comparable between the camps in the 
different districts, and there was no significant difference between the camps on the 
prevalence rate of Cryptosporidium (P>0.05), but it was slightly higher in Jenin camp 
than other camps in different districts. The prevalence rate was as follows; Jenin camp 
(15.8%, 3/19), Tulkarm camps (14.3%, 3/21), Hebron camps (13.0%, 3/23), Nablus 
camps (12.5%, 2/16), Ramallah camps (11.8%, 4/34) and Bethlehem camps (10.5%, 
2/19) (Figure 3.8). 
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Figure 3.8 The prevalence of Cryptosporidium in each district by camp  
 
3.7 The prevalence rate of Cryptosporidium in each district by villages 
The prevalence rate of Cryptosporidium infection was not found to be 
significantly different between the villages of different districts (P>0.05), but it seemed to 
be clear that prevalence rate was slightly higher in Hebron and Jenin villages. The 
prevalence rate was as follows;  Hebron villages (15.5%, 18/116), Jenin villages (14.3%, 
3/21), Nablus villages (13.0%, 3/23), Qalqilya villages (11.4%, 10/88), Ramallah villages 
(11.3%, 6/53), Tulkarm villages(10.0%, 2/20) and  Bethlehem villages (8.2%, 6/73) 
(Figure 3.9) . 
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Figure 3.9 The prevalence of Cryptosporidium in each district by villages.  
 
3.8. Prevalence of Cryptosporidium in the control group 
     The prevalence rate of Cryptosporidium in the control group is 3.2% (2/62); (Table 
3.2) and (Figure 3.10). 
 
3.2 Prevalence of Cryptosporidium in the control group. 
Region negative positive Total 
South 20 1 21 
Central 20 0 20 
North 20 1 21 
Total 60 2 62 
Percentage 96.8% 3.2% 100% 
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96.8%
 
   3.10 Prevalence of Cryptosporidium in the control group. 
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CHAPTER FOUR 
Discussion 
4.1 Prevalence rate of Cryptosporidium in the West Bank, Palestine. 
This study demonstrates clearly that the prevalence rate of Cryptosporidium in 
children with diarrhea in the West Bank is relatively high (11.6%) compared to 3.2% in 
the control group. So, this result is approximately close to other previous results like the 
the study which has been conducted at Caritas Baby Hospital with a prevalence rate of 
13.5% (Sallon, et al., 1988). Moreover, the prevalence rate of this study is relative to the 
one in Gaza Strip, where the prevalence rate of Cryptosporidium was (14.6%). The 
results are also consistent with those obtained in Egypt in 1987 with a prevalence rate 
(11.6%) (Michel, et al., 1987). 
This study has similar results to those obtained in Rawalpindi, Pakistan, with a 
prevalence rate of 10.3% in diarrheic children and 3.3% in the control group (Iqbal, et al., 
1999). Also, the study conducted in Iraq is not far from this result where the prevalence 
rate was 8.8% for children under five years old with a primary diagnosis of gastroenteritis 
(Mahdi, et al., 1996).  
The results obtained in this study are within the range (1.4%-40.9%) extracted 
from 100 reports with more than 133,175 diarrheic patients infected with 
Cryptosporidium in immunocompetent individuals in developing countries (Guerrant, 
1997). 
A study conducted in Irbid, Jordan showed different results where the prevalence 
rate of Cryptosporidium was 1.5% among children under five years of age (Youssef, et 
al., 2000). This difference could be attributed to the children socioeconomic class and 
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regional distribution. In addition to the hygienic condition and current methods of 
filtration and flocculation of water supplies done in Jordan which may be different from 
our localities in the West Bank.  
The high prevalence rate of Cryptosporidium in the West Bank may be attributed 
to wastewater disposal because 71.2% of people in southern part of the West Bank use 
porous cesspit compared to 61.7% and 56.1% in northern and central part of the West 
Bank respectively (Palestine Central Bureau of Statistics, 2004). Also, the sewage 
network is not well developed, yet it is used by 40.5% of the people in the central part of 
the West Bank compared to 26.3% and 30.6% in southern and northern parts of the West 
Bank respectively. Moreover domestic rain wells are deeper than cesspit levels in nearly 
80% of all regions of the West Bank (Palestine Central Bureau of Statistics, 2004). 
Ultimately, drinking water supplies will be contaminated and become a health hazard 
where transmission of pathogens is enhanced. 
 
4.2 The prevalence rate of Cryptosporidium in different districts 
The prevalence rate of Cryptosporidium is moderately higher in Hebron district 
(15.2%) than other districts. This might be attributed mainly to contamination of drinking 
water supplies. The Annual report conducted by the Central Public Health 
Laboratory(CPHL), Ministry of Health; in 2004 about contamination of drinking water; 
on 5698 samples of drinking water from different districts showed that 35.8% (177/494) 
of drinking water in Hebron is contaminated compared to 30.9% (138/447) in Toulkarm, 
24.7% (330/1338) in Jenin, 22.8% (313/1374) in Nablus, 22.3%(72/323) in Qalqilia, 
21.5% (123/572) in Ramallah, and 13.4% (67/501) in Bethlehem.  
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The mid-year report of 2005 about contamination of drinking water which has 
been conducted by (CPHL) on 3066 samples of drinking water also indicates that 
drinking water in Hebron is more contaminated (38.2%, 87/228) compared to 28.2% 
(188/667) in Nablus, 25.1% (106/423) in Ramallah, 24.9% (67/269) in Toulkarm, 22.6% 
(51/226) in Bethlehem, 18.8% (37/197) in Qalqilia, and 16.5% (118/715) in Jenin. 
 
A household environmental survey conducted by Palestine Central Bureau of 
Statistics in 2004 showed that 97.6% of people in the central part of West Bank use 
public water network for drinking water, 1.7% use domestic wells, 0.3% of people use 
springs and 0.4 use water tanks. While 77.6% of people in northern part of West Bank 
depend on public water network for drinking of water, 18.6% use domestic wells, 3.4% 
use water tanks and 0.4% use springs. Also 78% of people in southern part of the West 
Bank depend on public water network, 17.6% depend on domestic wells, 3.5% depend on 
water tanks, 0.3% depend on springs (Palestine Central Bureau of Statistics, 2004). These 
results show clearly that domestic wells almost are not used in the central part of West 
Bank compared to 17.8% and 18.6% in south and north of West Bank respectively.  
From these results it can be concluded that using domestic wells may contribute 
to contamination of drinking water if they are not cleaned periodically. The use of 
dumping sites as a method of solid wastes disposal without environmental control in the 
southern part of the West bank mainly in Hebron is very high (57.6%) compared to 
14.3% and 0% in the central  and the northern parts of the West Bank, respectively. 
Consequently, this will increase contamination and enhances the transmission of 
pathogens into human (Palestine Central Bureau of Statistics, 2004). 
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4.3 The Prevalence rate of Cryptosporidium in different regions 
The prevalence rate of Cryptosporidium seemed to be slightly higher in camps 
than in cities and villages and this could be the result of poor hygienic and sanitary 
conditions in camps in general, in addition to problems in water supplies and methods of 
wastewater disposal (Abu Mourad, 2004).  
 
4.4 The Prevalence rate of Cryptosporidium in males and females 
There was no significant difference between males and females on the prevalence 
rate of the parasite. However, females (12.4%) have a slightly higher prevalence rate than 
males (11.0%). This slight difference may be related to differences in social and hygienic 
habits practiced by both sexes. But the reason is unknown, because data on gender, race 
and ethnicity are incomplete currently. So conclusions could not be drawn about 
differences in the epidemiology of cryptosporidiosis based on gender (CDC, 2005). 
 
4.5 The Prevalence rate of Cryptosporidium by age categories of children 
 The highest prevalence rate was encountered in >0-5 years age category (14.4%) 
followed by > 5-10 years category (7.7%) and finally with >10-15 years age category 
(5.9%). This significant difference (P<0.05) could be attributed to the incomplete 
maturation of the immune system of the first category (>0-5) in addition to the lack of 
self awareness, personal hygiene and cleanliness at this critical age, therefore, they are 
most easily and frequently exposed to parasitic infections such as Cryptosporidium 
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infection (Hunter and Nichols, 2002; Abu Mourad, 2004, CDC, 2005), meaning that they 
are considered to be as the highest risk group in the study. 
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Recommendations 
 This study shows that the Prevalence rate of Cryptosporidium in the West Bank is 
relatively high in comparison with other countries. So there is a need for further 
researches in the future to identify the parasite in more details such as detection of 
Cryptosporidium in water supplies and sources of infection.  Screens for the parasite by 
other confirmatory methods such as immunofluorescent antibody (IFA), enzyme 
immunoassay (EIA) and Polymerase Chain Reaction (PCR) are needed.  
 Detection of the parasite should be done routinely in public and private laboratories. 
The modified acid fast method, which can be done within few minutes, may be adopted. 
Technicians should be trained to test for Cryptosporidium in public and private hospitals 
in the West Bank and Gaza Strip. 
 Help in the development of new strategies by the Ministry of Health to control the 
transmission of cryptosporidiosis. 
 Prevention of any future outbreaks of cryptosporidiosis and the identification of 
Cryptosporidium genotypes to determine the origin of the species of the parasite. 
 Awareness campaign should be conducted throughout the country about the importance 
of sanitary and hygienic practices in preventing parasitic infections including 
Cryptosporidium infection. 
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 Table 3.1 Distribution of Cryptosporidium prevalence rate (%) in children with diarrhea in the seven surveyed districts by gender, region 
and age categories. 
 
 
Gender Region Age Categories District Result Female Male City Village Camp >0 - 5 >5 - 10 >10 - 15 Total 
Positive 4(8.9%, 4/54) 6(9.5%, 6/63) 2(8%, 2/25) 6(8.2%, 6/73) 2(10.5%, 2/19) 10(8.5%, 10/117) - - 
Negative 50 57 23 67 17 107 - - Bethlehem 
Total 54 63 25 73 19 117 - - 
117 
Positive 13(21.3%, 13/61) 15(12.2%, 15/123) 7(15.6%, 7/45) 18(15.5%, 18/116) 3(13%, 3/23) 22(21.2%, 22/104) 4(8.5%, 4/47) 2(6.1%, 2/33) 
Negative 48 108 38 98 20 82 43 31 Hebron 
  Total 61 123 45 116 23 104 47 33 
184 
Positive 4(13.8%, 4/29) 5(14.7%, 5/34) 3(13%, 3/23) 3(14.3%, 3/21) 3(15.8%, 3/19) 6(21.4%, 6/28) 2(8.3%, 2/24) 1(9.1%. 1/11) 
Negative 25 29 20 18 16 22 22 10 
Jenin 
  Total 29 34 23 21 19 28 24 11 
63 
Positive 2(7.4%, 2/27) 5(13.9%, 5/36) 2(8.3%, 2/24) 3(13%, 3/23) 2(12.5%, 2/16) 6(17.1%, 6/35) 1(4.5%, 1/22) 0(0%, 0/6) 
Negative 25 31 22 20 14 29 21 6 Nablus 
  Total 27 36 24 23 16 35 22 6 
63 
Positive 6(10.7%, 6/56) 10(10.9%, 10/92) 6(10%, 6/60) 10(11.3%, 10/88) - 10(13.7%, 10/73) 4(8.1%, 4/49) 2(7.7%, 2/26) 
Negative 50 82 54 78 - 63 45 24 Qalqilya 
 Total 56 92 60 88 - 73 49 26 
148 
Positive 6(10.9%, 6/55) 6(8.1%, 6/74) 2(4.7%, 2/42) 6(11.3%, 6/53) 4(11.7%, 4/34) 8(11.6%, 8/69) 3(7.3%, 3/41) 1(5.2%, 1/19) 
Negative 49 68 40 47 30 61 38 18 Ramallah 
Total 55 74 42 53 34 69 41 19 
129 
Positive 3(12%, 3/25) 3(10.7%, 3/28) 1(6.6%, 1/15) 2(10%, 2/20) 3(14.3%, 3/21) 5(13.1%, 5/38) 1(8.3%, 1/12) 0(0%, 0/6) 
Negative 22 25 14 18 18 33 11 6  
Tulkarm Total 25 28 15 20 21 38 12 6 
56 
Total 307(12.4%, 38/307) 453(11%, 50/753) 234(9.8%,23/234) 394(12.2%, 48/394) 132(12.9%, 17/132) 
464(14.4%, 67/464) 195(7.7%, 
15/195) 
101(5.9%, 
6/101) 760 
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